CurrentUnitedHealthcarePolicy CSOH2026D0073.C

Self-Administered Medications (for Ohio Only)

Defines UnitedHealthcare Community Plan medical benefit policy for medications considered self‑administered in Ohio and governs coverage determination for those drugs on the Self‑Administered Medications List. Affects providers and claims for members covered under UnitedHealthcare Ohio plans.

Policy Summary

PayerUnitedHealthcare

PolicySelf-Administered Medications (for Ohio Only)

Policy CodePolicy CSOH2026D0073.C

Change TypeRoutine reviewno content changes

Effective DateJan 1, 2026

Next Review DateN/A

Key ActionRefer to the Self-Administered Medications List (for Ohio Only) for applicable HCPCS codes; clinician-administered formulations (e.g., IV infusion) of those drugs may be covered under the medical benefit.

SourceLink

POLICY UPDATE CHANGES

Routine review; no content changes.

1state-specific policy

Self-Administered Listreferenced code list

0637revenue code

0medical benefit reimbursement

Coverage Determination for Self‑Administered Medications

Classification as Self-Administered (leads to non-reimbursement on medical benefit)

Covered when ALL of the following are met (determines classification as self‑administered):

Self-administration classification criteria: Medication is not typically administered or directly supervised by a qualified provider or licensed/certified health professional in an outpatient setting; and medication does not require continuous or periodic monitoring immediately before, during, or after administration by a qualified provider or licensed/certified health professional in an outpatient setting; and route of administration is consistent with self-administration (e.g., oral, inhaled, intranasal, topical, rectal, subcutaneous, or self-injectable intramuscular injections); and dosage form is consistent with self-administration (e.g., prefilled syringe, auto-injector, tablet, capsule, suppository, nasal spray, metered dose inhaler, nebulized solution); and acuity of condition and frequency of administration are consistent with chronic disease/self-administration; and standards of medical practice allow for self-administration; and evaluation of established medical literature or compendia support self-administration

All listed bullets from Coverage Rationale must be considered when classifying a medication as self-administered.

Any applicable clinician‑administered dosage formulations (for example, intravenous infusion) of drugs listed on the Self‑Administered Medications List may be treated separately and considered for coverage under the medical benefit. Refer to the Self‑Administered Medications List (Ohio only) for the HCPCS codes UnitedHealthcare has determined to be self‑administered; those drugs’ clinician‑administered formulations remain eligible for medical benefit consideration.

Policy Summary

PayerUnitedHealthcare

PolicySelf-Administered Medications (for Ohio Only)

Policy CodePolicy CSOH2026D0073.C

Change TypeRoutine reviewno content changes

Effective DateJan 1, 2026

Next Review DateN/A

SourceLink

On This Page

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Self‑administered medications are not reimbursed on medical benefit plans. Medications administered by the patient that do not require direct supervision by a qualified provider or licensed/certified health professional are considered self‑administered and are therefore excluded from medical benefit reimbursement.

Referenced Codes and Coding Notes

Referenced Revenue/HCPCS Codesmixed

0637	Self-administered drugs (use this revenue code for self-administered drugs not requiring detailed coding)

Referenced code listHCPCS

Self-Administered Medications List

Refer to the Self-Administered Medications List (for Ohio Only) for applicable HCPCS codes for medications determined to be self-administered

Coding — General

ThresholdsN/A

Effective date2026-01-01

Policy numberCSOH2026D0073.C

Provider Responsibilities and Billing Guidance

Denial Risk

Denial risk for self-administered drugs

Claims for medications determined to be self-administered are not reimbursed under medical benefit plans and are at risk for denial. Providers should bill these products through the pharmacy/drug benefit when applicable and verify benefit coverage prior to administration or billing.

Self-administered medications are identified per the Coverage Rationale and the Self-Administered Medications List (Ohio only).
Use Revenue Code 0637 for self-administered drugs not requiring detailed coding where applicable.
Any clinician‑administered dosage formulations (e.g., IV infusions) of drugs on the Self‑Administered Medications List may be covered on the medical benefit—verify form and route.

Documentation Required

Governing documentation

When determining coverage, reference and follow applicable federal, state (Ohio Administrative Code 5160-1-01 and other OAC provisions), and contractual requirements for the member’s benefit plan. In the event of a conflict between this policy and federal, state (OAC), or contract terms, the federal, state (OAC), or contractual requirements govern. This policy is informational and does not replace plan documents or legal requirements.

Ohio Administrative Code 5160-1-01 and other applicable OAC provisions may affect coverage determinations.
Plan-specific contractual language and member benefits should be checked prior to rendering services or adjudicating claims.

Note

Use of utilization tools

UnitedHealthcare may use external utilization management tools and clinical criteria (for example, InterQual) to assist in administering benefits and making coverage determinations. Providers should follow the plan-specific utilization management processes and submission requirements for authorization and supporting documentation.

Third‑party clinical criteria (e.g., InterQual) may be applied to prior authorization or coverage reviews.
Follow the member’s plan-specific utilization management and prior authorization processes when requesting coverage for medications or clinician-administered formulations.

Background and Policy Scope

Self‑administered medications are those given by the patient without direct supervision or immediate monitoring by a qualified provider or licensed/certified health professional. Determination of self‑administration considers the usual route and dosage form, the need for monitoring, acuity and frequency of administration, standards of medical practice, and evaluation of medical literature and compendia (for example, FDA prescribing information, manufacturer literature, peer‑reviewed studies, evidence‑based guidelines, and drug compendia). When a medication meets these criteria it is classified as self‑administered and will not be covered under the medical benefit for Ohio plans.

Key Definitions

Definition of self-administered medications

DefinitionMedications administered by the patient that do not require direct supervision or immediate monitoring by a qualified provider or licensed/certified health professional.

Common routesOral, inhaled, intranasal, topical, rectal, subcutaneous, self-injectable intramuscular injections.

Common dosage formsPrefilled syringe, auto-injector, tablet, capsule, suppository, nasal spray, metered dose inhaler, nebulized solution.

Coverage implicationSelf-administered medications are not reimbursed on medical benefit plans for Ohio.

Clinician‑Administered Formulations and Site‑of‑Care Notes

Note

Coverage for clinician‑administered formulations in infusion settings

Clinician‑administered formulations (for example, IV infusion) of drugs that appear on the Self‑Administered Medications List may be covered under the medical benefit when administered in an appropriate clinical setting.

Self‑administered formulations remain not covered on the medical benefit; clinician‑administered dosage forms should be billed to the medical benefit when applicable.